Skip to main content
Venture Capital· 44-page report

Ramp Technologies VC Due Diligence

VC due diligence on Ramp ($32B corporate card platform) analyzing unit economics, competitive landscape, and IPO readiness.

What this research found

A 44-page venture capital due diligence report on Ramp Technologies, the corporate card and spend management platform valued at $32 billion as of November 2025. It traces the funding and valuation trajectory, splits the revenue model into interchange, software subscription, and float, benchmarks Ramp against Brex, Bill.com, Navan, and the legacy incumbents, and scores regulatory and concentration risks. The recommendation is a strong buy on an 18 to 24 month hold toward an initial public offering, with interchange regulation named as the principal threat.

  • Valuation stepped up four times in 2025 alone: a $150 million secondary at $13 billion in March, a $200 million Series E at $16 billion in June, $500 million at $22.5 billion in July, and $300 million at $32 billion in November, taking total funding to $2.3 billion.
  • The growth metrics behind that price: annualised revenue passed $1 billion in 2025, total payment volume reached $57 billion against $22.3 billion in 2023, customers exceeded 50,000 after doubling year over year, and the 2,200-plus enterprise accounts paying above $100,000 grew 133%.
  • Estimated net revenue retention of 125% to 135% sits well above the 102% median for SaaS companies, and customer lifetime value is put at 25 to 40 times acquisition cost.
  • Interchange regulation is the highest-rated risk, with potential margin compression of 30% to 40%. Credit interchange averages roughly 1.80% of transaction volume, and proposed US debit caps plus state-level restrictions add further uncertainty.
  • Ramp remains small against the incumbent: American Express holds about 30% of the corporate card market to Ramp's 1.5%, which frames both the growth runway and the competitive threat.
  • Valuation scenarios span a wide band — $50 to 60 billion in the bull case for 2027–2028, $28 to 35 billion in the base case, and $12 to 18 billion in the bear case — against a current multiple near 32 times forward revenue and an IPO readiness score of 8.3 out of 10.

How it was done

Company metrics, market sizing, competitor features, interchange economics, and retention benchmarks were gathered through structured web research using Perplexity Sonar Pro, supplemented by industry reports, company disclosures, and Federal Reserve interchange data. Those inputs supported a revenue-model breakdown across interchange, subscription, and float, a feature matrix against Brex, Bill.com and Divvy, Airbase, Navan, SAP Concur, and Expensify, a customer lifetime value build-up, a risk heatmap, and bull, base, and bear valuation scenarios. The output was a 44-page report with nine figures and 26 citations.

Data sources

  • Perplexity Sonar Pro web research — company metrics, market sizing, competitor and retention benchmarks
  • Industry reports from Mordor Intelligence and Fortune Business Insights
  • Federal Reserve debit card interchange fee reporting
  • Ramp disclosures and press coverage from Fortune, TechCrunch, FinTech Futures, and Sacra
  • SaaS retention benchmarks from SaaS Capital and ChartMogul

Limitations

Ramp is private, so revenue, retention, and volume figures rest on company disclosures and press coverage rather than audited filings, and the underlying research flags conflicting valuation reports and the absence of independent audit. Net revenue retention in particular is an estimate, and no peer-reviewed work on corporate card unit economics exists to check the model against.

How this research was produced

K-Dense Web planned and ran this venture capital investigation end to end — gathering the sources, carrying out the analysis, producing the figures, and drafting the report. The full session transcript, including every intermediate step, is available to view.

Share:
Venture Capital

CoreWeave VC Due Diligence

63-page VC due diligence on CoreWeave GPU cloud ($19B valuation) with unit economics, Porter's Five Forces, and risk assessment.

Economics

Macroeconomic Recession Prediction

Predict US recessions at 3, 6, and 12-month horizons using FRED macroeconomic indicators with XGBoost and Bayesian models.

Pharma/IP

GLP-1 Drug Patent Landscape

Map publication-patent relationships for GLP-1 agonists like Liraglutide and Tirzepatide to identify prior art timing.

Run this kind of analysis on your own question

Try K-Dense Web free and see how an AI co-scientist accelerates your research.